FDA Issues Guidance Recommending Global Standards for Bioequivalence Study – The FDA has issued the final version of Guidance for Industry #224 Bioequivalence: Blood Level Bioequivalence Study. It will help standardize the data recommendations associated with in vivo blood level bioequivalence (BE) for veterinary pharmaceutical products |